LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—

Filed today

—

Companies tracked

NSE & BSE

Listed on

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.

Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split

Data sourced from BSE India corporate announcements. More categories will be added over time.

Palash Securities Ltd

Palash Securities MD Change: Chand Bihari Patodia Replaced by Suraj Kumar Agrawal

BOARD ◆ Monitor Closely MEDIUM RISK

📅 Filed on BSE: 30 Mar 2026, 04:42 PM IST · BSE ID: 7baae28a-eae4-4dad-874f-271a61c2a6d2

View Original BSE Filing (PDF)

💡

In Simple Terms

The company's managing director stepped down and was replaced by a new one, subject to shareholder vote.

🤖 AI Summary

MD transition: Chand Bihari Patodia ceased 29 March 2026, replaced by Suraj Kumar Agrawal effective 30 March 2026
Agrawal appointed Managing Director for 3-year term: 30 March 2026 to 29 March 2029, without remuneration
Appointment subject to shareholder approval; Agrawal not debarred by SEBI or other authority
Agrawal added to reconstituted Audit Committee; three KMP authorized for Regulation 30 materiality determinations

🔢 Key Numbers — exact figures from BSE filing, not rounded

MD Term Length

3 years (30 March 2026 to 29 March 2029)

MD Remuneration

None disclosed (no remuneration)

Audit Committee Members Post-Reconstitution

4 members (1 Chairman + 3 Members)

🏢 How This Affects the Company

⚙️

Operational Impact

New Managing Director assumes leadership effective 30 March 2026. Audit Committee reconstituted with MD as member alongside three independent directors. Three KMP now jointly authorized for regulatory disclosures under Regulation 30.

⚠️

Risk Impact

Management continuity risk during transition period. New MD serves without remuneration — compensation terms unclear post-shareholder approval. Incoming MD has no apparent conflict (not debarred), but lack of disclosed track record increases execution uncertainty.

👥 What This Means For Shareholders

✅

Action Required

Shareholder approval required for Suraj Kumar Agrawal's appointment as Managing Director — vote timeline not yet disclosed in filing.

👤

Who Is Affected

All shareholders must vote on MD appointment. Individual shareholders and institutional holders have equal voting rights on Agrawal's 3-year tenure confirmation.

🔍

Management Signal

Board demonstrates planned governance succession and proactive Audit Committee reconstitution, signaling structured leadership transition rather than crisis replacement.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events

Shareholder approval meeting notice — watch for convocation date and voting results on MD appointment

First Board meeting minutes post-shareholder approval — confirm Agrawal's formal appointment and any compensation disclosure

Q4 FY26 or FY27 results announcement — track operational continuity and business performance under new MD leadership

MEDIUM RISK MD transition with pending shareholder approval and undisclosed remuneration structure creates governance and continuity risk until formal confirmation.

💡 Investor Takeaway

Palash Securities executed planned MD succession on 30 March 2026. Chand Bihari Patodia exited; Suraj Kumar Agrawal assumes role for 3-year term ending 29 March 2029, pending shareholder approval. New MD joins Audit Committee immediately. No remuneration disclosed.

⚖️ Strengths & Concerns

✅ Positives

Incoming MD cleared by SEBI — no debarment orders or regulatory sanctions against Suraj Kumar Agrawal
Audit Committee reconstituted promptly with MD included, maintaining governance continuity immediately

⚠️ Concerns

MD appointment without disclosed remuneration creates transparency gap — no salary, bonus, or benefit structure disclosed
Shareholder approval still pending — appointment contingent on shareholder vote, creating governance uncertainty until approved

📑 More from Palash Securities Ltd

Palash Securities Board Meeting to Approve Q2 FY27 Unaudited Financial Results

RESULTS · 03 Nov 2026

Palash Securities: Statutory Auditors Appointed for 5 Years

MANAGEMENT · 05 Aug 2026

Palash Securities Ltd: Suraj Kumar Agrawal Appointed MD for 3 Years

MANAGEMENT · 26 May 2026

Palash Securities Ltd: FY26 Audited Financial Results and Auditor Appointments

RESULTS · 15 May 2026

Palash Securities: Suraj Kumar Agrawal appointed Managing Director for 3 years

MANAGEMENT · 30 Mar 2026

Palash Securities: MD Chand Bihari Patodia tenure ends after three years

MANAGEMENT · 29 Mar 2026

All BSE filings we have analysed for Palash Securities Ltd.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.